26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
TriviumVet work with The Ohio State University evaluating the benefit of Rapamycin in cats.
15th April
We are delighted to be working with The Ohio State University on an exciting clinical trial evaluating the benefit a new drug in cats with chronic kidney disease. Details of the...
TriviumVet support UC Davis and the Morris Animal Foundation in a novel research.
11th April
We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS) is a common heart defect in dogs which often leads to...
A great catch up with our colleagues in the US.
11th March
Our CTO Stuart Fitzgerald and Regulatory Affairs Manager Susan Kennedy had a successful trip to the US where they got to connect and catch up with thought leaders in veterinary...
CEO Louise Grubb won Entrepreneur of The Year at the 2021 Waterford Business Awards.
9th March
A great celebration for our female led company as our CEO Louise Grubb has won Entrepreneur of The Year at the 2021 Waterford Business Awards. Louise Grubb, founder and CEO of...
TriviumVet represented at the VMX Conference presented by North American Veterinary Community
1st February
It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference presented by North American Veterinary Community...
Recent visit with our Researchers at North Carolina State University College of Veterinary Medicine.
31st January
Our CEO Louise Grubb and CTO Stuart Fitzgerald were delighted to catch up with Dean Kate Meurs and many of our wonderful researchers at North Carolina State University College of...
TriviumVet represented by Susan Kennedy at the information day for SMEs in the veterinary medicines sector organised by European Medicines Agency.
10th November
Susan presented TriviumVet’s experience of receiving scientific advice from the EMA. The event gave attendees the opportunity to hear first-hand experience of SME’s and marketing...
TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – to treat dilated cardiomyopathy in dogs.
10th November
TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second...
IHS Markit Article – TriviumVet gearing up for pet pipeline launches to bridge therapeutic gaps
15th September
Ireland’s TriviumVet is a therapeutics and diagnostics start-up targeting a range of unmet needs in companion animal health. Having weathered the COVID-19 pandemic, the company is...
FDA’s Center for Veterinary Medicine deems TriviumVet’s feline HCM program eligible for expanded conditional approval pathway
14th September
TriviumVet™ are delighted to announce that the Food and Drug Administration’s Center for Veterinary Medicine has determined that our feline hypertrophic cardiomyopathy (HCM)...
TriviumVet support UC Davis and the Morris Animal Foundation in a novel research.
11th April
We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS) is a common heart defect in dogs which often leads to...
A great catch up with our colleagues in the US.
11th March
Our CTO Stuart Fitzgerald and Regulatory Affairs Manager Susan Kennedy had a successful trip to the US where they got to connect and catch up with thought leaders in veterinary...
CEO Louise Grubb won Entrepreneur of The Year at the 2021 Waterford Business Awards.
9th March
A great celebration for our female led company as our CEO Louise Grubb has won Entrepreneur of The Year at the 2021 Waterford Business Awards. Louise Grubb, founder and CEO of...
TriviumVet represented at the VMX Conference presented by North American Veterinary Community
1st February
It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference presented by North American Veterinary Community...
Recent visit with our Researchers at North Carolina State University College of Veterinary Medicine.
31st January
Our CEO Louise Grubb and CTO Stuart Fitzgerald were delighted to catch up with Dean Kate Meurs and many of our wonderful researchers at North Carolina State University College of...
TriviumVet represented by Susan Kennedy at the information day for SMEs in the veterinary medicines sector organised by European Medicines Agency.
10th November
Susan presented TriviumVet’s experience of receiving scientific advice from the EMA. The event gave attendees the opportunity to hear first-hand experience of SME’s and marketing...
TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – to treat dilated cardiomyopathy in dogs.
10th November
TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second...
IHS Markit Article – TriviumVet gearing up for pet pipeline launches to bridge therapeutic gaps
15th September
Ireland’s TriviumVet is a therapeutics and diagnostics start-up targeting a range of unmet needs in companion animal health. Having weathered the COVID-19 pandemic, the company is...
FDA’s Center for Veterinary Medicine deems TriviumVet’s feline HCM program eligible for expanded conditional approval pathway
14th September
TriviumVet™ are delighted to announce that the Food and Drug Administration’s Center for Veterinary Medicine has determined that our feline hypertrophic cardiomyopathy (HCM)...